Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Sep 2023. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5257258013 | Mesalazine 1.6 g gastro-resistant and prolonged-release oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5257259017 | Product containing precisely mesalazine 1.6 gram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5257260010 | Mesalamine 1.6 g gastro-resistant and prolonged-release oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mesalazine 1.6 g gastro-resistant and prolonged-release oral tablet | Is a | Product containing only mesalazine in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Mesalazine 1.6 g gastro-resistant and prolonged-release oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Mesalazine 1.6 g gastro-resistant and prolonged-release oral tablet | Has precise active ingredient | Mesalazine | true | Inferred relationship | Some | 1 | |
| Mesalazine 1.6 g gastro-resistant and prolonged-release oral tablet | Has basis of strength substance (attribute) | Mesalazine | true | Inferred relationship | Some | 1 | |
| Mesalazine 1.6 g gastro-resistant and prolonged-release oral tablet | Has presentation strength numerator unit | g | true | Inferred relationship | Some | 1 | |
| Mesalazine 1.6 g gastro-resistant and prolonged-release oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Mesalazine 1.6 g gastro-resistant and prolonged-release oral tablet | Has manufactured dose form | Gastro-resistant and prolonged-release oral tablet | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR